The World Health Organization (WHO) African Region has raised the alarm over the continued high number of deaths from sickle cell disease, particularly among children under five, adolescents, and pregnant women.
In a statement marking World Sickle Cell Day, WHO emphasized that while effective treatments for the genetic blood disorder exist, access to these lifesaving interventions remains limited—especially in low-income communities across Sub-Saharan Africa.
“Deaths from sickle cell disease complications occur mostly in children under five years, adolescents, and pregnant women,” the WHO Africa office stated in a post on its official X (formerly Twitter) account.
Sickle cell disease is a hereditary condition that affects red blood cells, leading to painful episodes, increased risk of infections, organ damage, and premature death.
Sub-Saharan Africa bears the highest burden globally, with thousands of children born with the condition each year.
Many do not live to see their fifth birthday due to delayed diagnosis and lack of comprehensive care.
Health experts note that early screening, regular use of antibiotics, timely vaccinations, access to blood transfusions, and specialist care can significantly reduce complications and improve outcomes. However, such services remain out of reach for most families affected by the disease.
WHO is urging African governments and health development partners to prioritize sickle cell disease in their national health strategies.
The organization is calling for expanded access to diagnosis, treatment, and care, with a focus on equity and sustainability.
“Ensuring that no child dies from a treatable condition like sickle cell disease should be a public health imperative,” the WHO noted.
As countries move toward universal health coverage, advocates stress the need for increased investment in sickle cell programs to close the treatment gap and save lives.